Lancet Reg Health Am
November 2024
Background: This study addresses the rising burden of type 2 diabetes mellitus, and explores the potential of teleconsultation, as an alternative for diabetes management. The primary objective was to test the hypothesis that teleconsultation is non-inferior to face-to-face consultation in terms of glycaemic control measured as glycated haemoglobin (HbA1c) (non-inferiority margin for the upper confidence interval for the difference between groups of 0,5% in HbA1c) for type 2 diabetes mellitus patients referred from Primary Healthcare to Specialized Care within the SUS.
Methods: TELECONSULTA, is a randomized, pragmatic, phase 2, single-centre, open-label, non-inferiority trial conducted in Joinville, Brazil.
Objective: To present the results of a cost analysis of remote consultations (teleconsultations) compared to in-person consultations for patients with type 2 diabetes, in the Brazilian public healthcare system (SUS) in the city of Joinville, Santa Catarina (SC). In addition to the costs from the local manager's perspective, the article also presents estimates from the patient's perspective, based on the transportation costs associated with each type of consultation.
Method: Data were collected from 246 consultations, both remote and in-person, between 2021 and 2023, in the context of a randomized clinical trial on the impact of teleconsultation carried out in the city of Joinville, SC.
Objectives: To translate into Portuguese, perform cross-cultural adaptation and to evaluate the psychometric properties of the Summary of Diabetes Self-Care Activities Questionnaire - SDSCA.
Materials And Methods: The process followed the international guidelines for the adaptation and evaluation of psychometric properties. The Cronbach's alpha (α) was determined to evaluate the internal consistency (inter-itens correlation) and the reliability (test-retest and inter-evaluator correlation).